Page last updated: 2024-09-05

sorafenib and Leukemia, Myelomonocytic, Juvenile

sorafenib has been researched along with Leukemia, Myelomonocytic, Juvenile in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Braun, BS; Chao, AK; Dvorak, CC; Golden, C; Hecht, A; Koegel, AK; Lee, AG; Loh, ML; Meyer, JA; Smith, CC; Stieglitz, E; Sweet-Cordero, EA; Tarver, T; Van Ziffle, J	1

Other Studies

1 other study(ies) available for sorafenib and Leukemia, Myelomonocytic, Juvenile

Article	Year
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing. Leukemia, 2020, Volume: 34, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line; Exome Sequencing; fms-Like Tyrosine Kinase 3; Humans; Infant; Intracellular Signaling Peptides and Proteins; Leukemia, Myelomonocytic, Juvenile; Male; Mice; Microfilament Proteins; Mutation; Sequence Analysis, RNA; Sorafenib	2020

Article

Year

Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.

Leukemia, 2020, Volume: 34, Issue:2

Topics: Animals; Antineoplastic Agents; Cell Line; Exome Sequencing; fms-Like Tyrosine Kinase 3; Humans; Infant; Intracellular Signaling Peptides and Proteins; Leukemia, Myelomonocytic, Juvenile; Male; Mice; Microfilament Proteins; Mutation; Sequence Analysis, RNA; Sorafenib

2020